Search Results - "Hoch, Lucile"
-
1
Targeting of Smoothened for therapeutic gain
Published in Trends in pharmacological sciences (Regular ed.) (01-05-2014)“…Highlights • Smo antagonists have potential for cancer therapy. • Positive modulators of Smo may also be therapeutics. • Models of canonical and noncanonical…”
Get full text
Journal Article -
2
Generation of three induced pluripotent stem cell lines from patients with glycogen storage disease type III
Published in Stem cell research (01-10-2023)“…Glycogen storage disease type III (GSDIII) is an autosomal recessive disorder characterized by a deficiency of glycogen debranching enzyme (GDE) leading to…”
Get full text
Journal Article -
3
Identification of thiostrepton as a pharmacological approach to rescue misfolded alpha-sarcoglycan mutant proteins from degradation
Published in Scientific reports (06-05-2019)“…Limb-girdle muscular dystrophy type 2D (LGMD2D) is characterized by a progressive proximal muscle weakness. LGMD2D is caused by mutations in the gene encoding…”
Get full text
Journal Article -
4
Dual Blockade of Misfolded Alpha-Sarcoglycan Degradation by Bortezomib and Givinostat Combination
Published in Frontiers in pharmacology (27-04-2022)“…Limb-girdle muscular dystrophy type R3 (LGMD R3) is a rare genetic disorder characterized by a progressive proximal muscle weakness and caused by mutations in…”
Get full text
Journal Article -
5
Skeletal Muscle Cells Derived from Induced Pluripotent Stem Cells: A Platform for Limb Girdle Muscular Dystrophies
Published in Biomedicines (16-06-2022)“…Limb girdle muscular dystrophies (LGMD), caused by mutations in 29 different genes, are the fourth most prevalent group of genetic muscle diseases. Although…”
Get full text
Journal Article -
6
Pathological modeling of glycogen storage disease type III with CRISPR/Cas9 edited human pluripotent stem cells
Published in Frontiers in cell and developmental biology (11-05-2023)“…Glycogen storage disease type III (GSDIII) is a rare genetic disease caused by mutations in the gene encoding the glycogen debranching enzyme (GDE). The…”
Get full text
Journal Article -
7
MRT‐92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor
Published in The FASEB journal (01-05-2015)“…ABSTRACT The Smoothened (Smo) receptor, a member of class F G protein‐coupled receptors, is the main transducer of the Hedgehog (Hh) signaling pathway…”
Get full text
Journal Article -
8
A functional mini-GDE transgene corrects impairment in models of glycogen storage disease type III
Published in The Journal of clinical investigation (01-01-2024)“…Glycogen storage disease type III (CSDIII) is a rare inborn error of metabolism affecting liver, skeletal muscle, and heart due to mutations of the AGŁ gene…”
Get full text
Journal Article -
9
A functional mini-GDE transgene corrects impairment in models of glycogen storage disease type III
Published in The Journal of clinical investigation (16-01-2024)“…Glycogen storage disease type III (GSDIII) is a rare inborn error of metabolism affecting liver, skeletal muscle, and heart due to mutations of the AGL gene…”
Get full text
Journal Article -
10
Hedgehog associated to microparticles inhibits adipocyte differentiation via a non-canonical pathway
Published in Scientific reports (24-03-2016)“…Hedgehog (Hh) is a critical regulator of adipogenesis. Extracellular vesicles are natural Hh carriers, as illustrated by activated/apoptotic lymphocytes…”
Get full text
Journal Article -
11
Design, synthesis and biological characterization of a new class of osteogenic (1H)-quinolone derivatives
Published in European journal of medicinal chemistry (04-10-2016)“…Smoothened (Smo) is the signal transducer of the Hedgehog (Hh) pathway and its stimulation is considered a potential powerful tool in regenerative medicine to…”
Get full text
Journal Article -
12
Pathological modelling of pigmentation disorders associated with Hutchinson-Gilford Progeria Syndrome (HGPS) revealed an impaired melanogenesis pathway in iPS-derived melanocytes
Published in Scientific reports (14-06-2018)“…Hutchinson-Gilford Progeria Syndrome (HGPS) is a rare genetic disorder that leads to premature aging. In this study, we used induced pluripotent stem cells to…”
Get full text
Journal Article -
13
Discovery, molecular and pharmacological characterization of GSA-10, a novel small-molecule positive modulator of Smoothened
Published in Molecular pharmacology (01-05-2013)“…Activation of the Smoothened (Smo) receptor mediates Hedgehog (Hh) signaling. Hh inhibitors are in clinical trials for cancer, and small-molecule Smo agonists…”
Get more information
Journal Article -
14
Synergism of dual AAV gene therapy and rapamycin rescues GSDIII phenotype in muscle and liver
Published in JCI insight (16-05-2024)“…Glycogen storage disease type III (GSDIII) is a rare metabolic disorder due to glycogen debranching enzyme (GDE) deficiency. Reduced GDE activity leads to…”
Get full text
Journal Article -
15
Structure of the Smoothened receptor
Published in M.S. Médecine sciences (01-10-2013)“…The Smoothened (Smo) receptor is a major component involved in signal transduction of the Hedgehog (Hh) morphogens both during embryogenesis and in the adult…”
Get more information
Journal Article